The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S.

The Trump administration's aid freeze affects HIV treatment access. Find out how organizations are coping with the directive.

The latest waiver appeared to give the go-ahead for funding for medication under PEPFAR, a major US programme against ...

The current U.S. government, under the leadership of Donald Trump, has decided to freeze funding for the President’s ...

Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to ...

Canadian scientists say the uncertainty surrounding U.S. President Donald Trump's pause on federal health spending there ...

Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.

Despite the decision by US President Donald Trump to halt foreign development aid, which threatens the availability of free ...

Uganda sought to dispel fears among HIV patients that a US aid freeze will interrupt treatment and promised that such ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

The President’s Emergency Program for AIDS Relief is in danger of shuttering. The decision could kill hundreds of thousands of people and kickstart an epidemic.

The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future ...